Everyone expects something from the drug industry. Physicians and patients, investors, regulators and administrators all have an active interest. Everyone wants to know what makes drugs ‘work’ medically and economically. Why are drugs so expensive? Is it the drug companies or investors who demand high profits? What governs the pharmacoeconomics? Why are so few diseases treatable? This book opens the windows and doors of the industry telling the story of drug development by using real stories from inside the process."[This book] is very readable and insightful. I am hopeful that many people will pick it up, and develop a better appreciation for what goes into making the treatments that everyone wants!" - Dennis W. Choi, M.D., Sr. VP Merck (2006) "Anyone who thinks solutions to drug development are just around the corner would be well-advised to get this insider's views as to where the real problems lie." - Floyd Bloom, CEO Neurome, former Editor of Science magazine (2006) "...a very informative and exciting book filling an important niche. Very easy to read, it encouraged me to think about several things." - Richard Nass, Vanderbilt University (2006)
Informacje dodatkowe o Drug Discovery From Bedside to Wall Street:
Wydawnictwo: inne
Data wydania: b.d
Kategoria: Medycyna i zdrowie
ISBN:
978-0-12-369533-8
Liczba stron: 0
Sprawdzam ceny dla ciebie ...
Chcę przeczytać,